Barclays’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-31,187
| Closed | -$161K | – | 4669 |
|
|
2019
Q2 | $161K | Buy |
31,187
+13,915
| +81% | +$71.8K | ﹤0.01% | 3321 |
|
|
2019
Q1 | $62K | Buy |
17,272
+15,386
| +816% | +$55.2K | ﹤0.01% | 3556 |
|
|
2018
Q4 | $11K | Sell |
1,886
-15,263
| -89% | -$89K | ﹤0.01% | 3534 |
|
|
2018
Q3 | $100K | Buy |
17,149
+13,871
| +423% | +$80.9K | ﹤0.01% | 3418 |
|
|
2018
Q2 | $14K | Sell |
3,278
-10,522
| -76% | -$44.9K | ﹤0.01% | 3793 |
|
|
2018
Q1 | $61K | Buy |
13,800
+7,065
| +105% | +$31.2K | ﹤0.01% | 3417 |
|
|
2017
Q4 | $36K | Buy |
6,735
+5,244
| +352% | +$28K | ﹤0.01% | 3484 |
|
|
2017
Q3 | $9K | Sell |
1,491
-3,205
| -68% | -$19.3K | ﹤0.01% | 3489 |
|
|
2017
Q2 | $34K | Sell |
4,696
-10,855
| -70% | -$78.6K | ﹤0.01% | 3133 |
|
|
2017
Q1 | $83K | Buy |
15,551
+14,312
| +1,155% | +$76.4K | ﹤0.01% | 2916 |
|
|
2016
Q4 | $9K | Sell |
1,239
-1,591
| -56% | -$11.6K | ﹤0.01% | 3308 |
|
|
2016
Q3 | $26K | Buy |
2,830
+2,348
| +487% | +$21.6K | ﹤0.01% | 2956 |
|
|
2016
Q2 | $3K | Buy |
482
+300
| +165% | +$1.87K | ﹤0.01% | 3233 |
|
|
2016
Q1 | $1K | Sell |
182
-304
| -63% | -$1.67K | ﹤0.01% | 3378 |
|
|
2015
Q4 | $2K | Sell |
486
-9,422
| -95% | -$38.8K | ﹤0.01% | 3051 |
|
|
2015
Q3 | $80K | Buy |
9,908
+9,307
| +1,549% | +$75.1K | ﹤0.01% | 2442 |
|
|
2015
Q2 | $9K | Sell |
601
-651
| -52% | -$9.75K | ﹤0.01% | 3361 |
|
|
2015
Q1 | $20K | Sell |
1,252
-8,084
| -87% | -$129K | ﹤0.01% | 3115 |
|
|
2014
Q4 | $159K | Sell |
9,336
-200,951
| -96% | -$3.42M | ﹤0.01% | 2466 |
|
|
2014
Q3 | $2.1M | Buy |
210,287
+209,765
| +40,185% | +$2.1M | ﹤0.01% | 1362 |
|
|
2014
Q2 | $7K | Buy |
522
+183
| +54% | +$2.45K | ﹤0.01% | 3812 |
|
|
2014
Q1 | $6K | Sell |
339
-779
| -70% | -$13.8K | ﹤0.01% | 3960 |
|
|
2013
Q4 | $20K | Buy |
1,118
+557
| +99% | +$9.96K | ﹤0.01% | 3749 |
|
|
2013
Q3 | $9K | Buy |
+561
| New | +$9K | ﹤0.01% | 3686 |
|